HGSNAT Gene: Heparan-α-Glucosaminide N-Acetyltransferase

HGSNAT encodes the lysosomal enzyme responsible for acetyl-CoA-dependent acetylation of heparan sulfate, critical for its degradation; mutations cause mucopolysaccharidosis IIIC (Sanfilippo syndrome type C).

Gene Information Card

Symbol HGSNAT
Full Name Heparan-α-Glucosaminide N-Acetyltransferase
Gene Type Protein coding
Chromosomal Location 8p11.21
NCBI Gene ID 138050 ncbi.nlm.nih.gov/gene/138050
Ensembl ID ENSG00000104419
UniProt ID Q68CP4
OMIM ID 610453
HGNC ID 26527
Aliases MPS3C, TMEM76, FLJ12571

Description

The HGSNAT gene encodes heparan-α-glucosaminide N-acetyltransferase, a lysosomal transmembrane enzyme that catalyzes the acetylation of the terminal glucosamine residue of heparan sulfate using acetyl-CoA as a donor. This acetylation is a prerequisite for subsequent degradation by α-N-acetylglucosaminidase. Defects in HGSNAT lead to accumulation of heparan sulfate and cause mucopolysaccharidosis type IIIC (Sanfilippo syndrome type C), a severe autosomal recessive lysosomal storage disorder characterized by progressive neurodegeneration.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Mucopolysaccharidosis type IIIC (Sanfilippo syndrome type C) Loss-of-function mutations in HGSNAT impair heparan sulfate acetylation, leading to lysosomal accumulation of heparan sulfate and neurodegeneration. ClinVar, OMIM #252930
Mucopolysaccharidosis III (Sanfilippo syndrome) – general HGSNAT mutations cause subtype C of MPS III, with identical clinical phenotype to other subtypes. OMIM #252930, NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 5.2 Low
Liver 3.8 Low
Kidney 4.1 Low
Lung 2.9 Low
Heart 3.0 Low
Skeletal muscle 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK 293 4.5 Embryonic kidney cell line
HeLa 3.2 Cervical carcinoma cell line
HepG2 3.9 Hepatocellular carcinoma cell line
SH-SY5Y 5.0 Neuroblastoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.234+1G>A Splice donor Unknown Loss of function; associated with MPS IIIC
c.493C>T (p.Arg165*) Nonsense Unknown Premature stop; loss of function
c.852-1G>C Splice acceptor Unknown Loss of function
c.1129C>T (p.Arg377Trp) Missense Unknown Likely loss of function; reduced enzyme activity
Mutation functional classification

Loss of Function (LOF)

Most reported HGSNAT mutations (nonsense, frameshift, splice site, missense) result in complete or partial loss of enzymatic activity, leading to lysosomal heparan sulfate accumulation.

Gain of Function (GOF)

No gain-of-function mutations have been reported for HGSNAT.

Dominant Negative (DN)

No dominant-negative mutations have been described; MPS IIIC is inherited in an autosomal recessive manner.

Pathways

Glycosaminoglycan degradation (KEGG: hsa00531)
Lysosome (KEGG: hsa04142)
Heparan sulfate/heparin metabolism (Reactome: R-HSA-1638091)

Protein Summary

HGSNAT is a 635-amino acid lysosomal transmembrane protein with a single N-terminal transmembrane domain. It functions as a homodimer and uses acetyl-CoA to acetylate the terminal α-glucosamine residue of heparan sulfate, a critical step in its lysosomal degradation. The protein is ubiquitously expressed at low levels, with highest expression in brain and liver. Defects cause Sanfilippo syndrome type C.

Related Products

Product name Cat.No. Species Gene ID
HGSNAT Knockout HEK293 Cell Line EDJ-KQ2968 Human 138050 Details Get a Quote
HGSNAT Knockout A-549 Cell Line EDJ-KQ24125 Human 138050 Details Get a Quote
HGSNAT Knockout HeLa Cell Line EDJ-KQ24127 Human 138050 Details Get a Quote
HGSNAT Knockout HCT 116 Cell Line EDJ-KQ22755 Human 138050 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: